Medicxi — 2015 Investments
1 investments dated 2015 · listed companies and verified rows first · show all
Minerva Neurosciencesminervaneurosciences.comNASDAQ: NERVMar 2015SEC filingmedium confidence
Minerva Neurosciences is a clinical-stage biopharmaceutical company developing product candidates for central nervous system disorders.
BiotechHealthtechWaltham, US
Joseph Reilly(Executive Officer)Geoff Race(Executive Officer)Fred Ahlholm(Executive Officer)Remy Luthringer(Executive Officer, Director)Mark Levine(Executive Officer)
BoardMichele Ollier(Director)in
Board seatFrancesco De Rubertis· per SEC Form D · $31M raise · filed Mar 2015
Co-investorsVivo Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.